FindTrial
Sign In

The role of innate lymphoid cells in chronic rhinosinusitis

The role of innate lymphoid cells in chronic rhinosinusitis

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-jRCT1090220165
Enrollment
40
Registered
2014-02-20
Start date
2014-02-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis

Interventions

Intervention type:PROCEDURE Name of intervention:none Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application:NOT APPLICABLE Dose per administrati

Sponsors

Yoshinori Matsuwaki
Lead Sponsor
Kazuhiro Oomura Keisuke Uno
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patient with eosinophilic chronic rhinosinusitis,non-eosinophilic chronic rhinosinusitis,allergic fungul rhinosinusitis and pituitary tumor for control.

Exclusion criteria

Exclusion criteria: patient with anemia

Design outcomes

Primary

MeasureTime frame
innate lymphoid cells in nasal polyp—

Secondary

MeasureTime frame
the activity of innate lymphoid cells in nasal polyp—

Countries

Japan

Contacts

Public ContactYoshinori Matsuwaki

The Jikei University school of medicine

matuwaki@jikei.ac.jp+81-3-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026